Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer

Gut

Volumn 52, Issue 9, 2003, Pages 1304-1307

  Plentz, R R ^a   Wiemann, S U ^a   Flemming, P ^a   Meier, P N ^a   Kubicka, S ^a   Kreipe, H ^a   Manns, M P ^a   Rudolph, K L ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ANAPHASE; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONNECTIVE TISSUE; DYSPLASIA; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; TELOMERE;

ADENOMA; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONNECTIVE TISSUE; EPITHELIAL CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; TELOMERE; TUMOR MARKERS, BIOLOGICAL;

EID: 0042887525     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.9.1304     Document Type: Article

References (30)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal- tumor development. N Engl J Med 1988;319:525-32.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
3. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER + tumor cells. Cell 1993;17:1227-36.
4. Honchel R, Halling KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994;54:1159-63.
5. Young J, Leggett B, Gustafson C, et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 1993;2:351-4.
6. Okamoto M, Sasaki M, Sugio K, et al. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature 1988;331:273-7.
7. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15:234-45.
8. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998;51:901-9.
9. Barletta A, Marzullo F, Pellecchia A, et al. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Anticancer Res 1998;18:1677-82.
10. Suzuki S, Mizuno M, Tomoda J, et al. Flow cytometric analysis of the DNA content in colorectal adenomas with focal cancers. Gastroenterology 1995;109:1098-104.
11. Muleris M, Zafrani B, Validire P, et al. Cytogenetic study of 30 colorectal adenomas. Cancer Genet Cytogenet 1994;74:104-8.
12. Enblad P, Glimelius B. The DNA content in rectal adenomas. Anticancer Res 1989;9:749-52.
13. Giaretti W, Sciallero S, Bruno S, et al. DNA flow cytometry of endoscopically examined colorectal adenomas and adenocarcinomas. Cytometry 1988;9:238-44.
14. Gob HS, Jass JR. DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 1986;39:387-92.
15. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
16. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
17. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297:565-9.
18. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999;96:701-12.
19. Rudolph KL, Millard M, Bosenberg MW, et al. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001;28:155-9.
20. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-5.
21. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-8.
22. Engelhardt M, Drullinsky P, Guillem J, et al. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-41.
23. Nakamura K, Furugori E, Esaki Y, et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett 2000;158:179-84.
24. Takagi S, Kinouchi Y, Hiwatashi N, et al. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 1999;86:1431-61.
25. Engelhardt M, Albanell J, Drullinsky P, et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin Cancer Res 1997;3:1849-57.
26. Kim HR, Kim YJ, Kim HJ, et al. Telomere length changes in colorectal cancers and polyps. J Korean Med Sci 2002;17:360-5.
27. Tang R, Cheng AJ, Wang JY, et al. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res 1998;58:4052-4.
28. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
29. Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorgenesis in the INK4a (delta2/3) cancer-prone mouse. Cell 1999;97:515-25.
30. Gonzalez-Suarez E, Samper E, Flores JM, et al. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000;26:114-17.